Literature DB >> 32562189

XPC as breast cancer susceptibility gene: evidence from genetic profiling, statistical inferences and protein structural analysis.

Saima Shakil Malik1,2, Ayisha Zia3, Sajid Rashid3, Sumaira Mubarik4, Nosheen Masood5, Mubashar Hussain6, Azra Yasmin5, Razia Bano7.   

Abstract

BACKGROUND: Gene polymorphisms that affect nucleotide excision repair (NER) pathway may link with higher susceptibility of breast cancer (BC); however, the significance of these associations may vary conferring to the individual ethnicity. Xeroderma pigmentosum complementation gene (XPC) plays a substantial role in recognizing damaged DNA during NER process. OBJECTIVE AND METHODS: To estimate the relationship among XPC polymorphisms and breast cancer (BC) risk, we carried out a case-control-association study with 493 BC cases and 387 controls using TETRA-ARMS-PCR. Distributional differences of clinical features, demographic factors and XPC polymorphisms among BC cases and controls were examined by conditional logistic regression model. Kaplan-Meier test was applied to predict survival distributions and protein structure was predicted using computational tools.
RESULTS: Obesity, consanguinity, positive marital status and BC family history were associated (P ≤ 0.01) with higher BC risk. Genotyping revealed significant involvement (P ≤ 0.01) of two XPC polymorphisms rs2228001-A > C (OR = 3.8; CI 1.9-7.6) and rs2733532-C > T (OR = 2.6; CI 1.4-5.03) in BC development, asserting them potential risk factors for increased BC incidence. However, no association (P > 0.05) was detected for overall or progression free survival for both XPC polymorphisms possibly due to shorter follow-up time (45 months). As compared to normal XPC structure, pronounced conformational changes have been observed in the C-terminus of XPCQ939K, bearing rs2228001-A > C substitution. In XPCQ939K, two additional α-helices were observed at A292-E297 and Y252-R286, while L623-M630 and L649-L653 helices were converted into loop conformation.
CONCLUSION: In conclusion, both XPC polymorphisms confer significant association with increased BC risk. rs2228001 substitution may change the structural and functional preferences of XPC C-terminus, while rs2733532 may have regulatory role thereby leading to potential BC risk.

Entities:  

Keywords:  Breast cancer; Overall survival; Progression free survival; Protein structure; XPC polymorphisms

Mesh:

Substances:

Year:  2020        PMID: 32562189     DOI: 10.1007/s12282-020-01121-z

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  4 in total

1.  METTL3 promotes homologous recombination repair and modulates chemotherapeutic response in breast cancer by regulating the EGF/RAD51 axis.

Authors:  Enjie Li; Mingyue Xia; Yu Du; Kaili Long; Feng Ji; Feiyan Pan; Lingfeng He; Zhigang Hu; Zhigang Guo
Journal:  Elife       Date:  2022-05-03       Impact factor: 8.713

Review 2.  Xeroderma Pigmentosum Complementation Group C (XPC): Emerging Roles in Non-Dermatologic Malignancies.

Authors:  Nawar Al Nasrallah; Benjamin M Wiese; Catherine R Sears
Journal:  Front Oncol       Date:  2022-04-21       Impact factor: 5.738

3.  Genetic Variations in Nucleotide Excision Repair Pathway Genes and Risk of Allergic Rhinitis.

Authors:  Wenlong Liu; Qingxiang Zeng; Yinhui Zeng; Yiquan Tang; Renzhong Luo
Journal:  Mediators Inflamm       Date:  2022-06-03       Impact factor: 4.529

4.  Epidemiological and sociodemographic transitions of female breast cancer incidence, death, case fatality and DALYs in 21 world regions and globally, from 1990 to 2017: An Age-Period-Cohort Analysis.

Authors:  Sumaira Mubarik; Yong Yu; Fang Wang; Saima Shakil Malik; Xiaoxue Liu; Muhammad Fawad; Fang Shi; Chuanhua Yu
Journal:  J Adv Res       Date:  2021-08-02       Impact factor: 12.822

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.